India Exchange Filings

Suraksha Diagnostic Q2 FY27 Results Corrigendum

Suraksha Diagnostic Ltd corrects Q2 FY27 results, reporting ₹1,005.75 million total income and 69% YoY PAT growth

  • EBITDA rose 45% YoY to ₹363.17 million; margin expanded to 36.7% from 31.7%.
  • PAT increased 69% YoY to ₹149.50 million.
  • Total tests reached 2.40 million (+9%); tests per patient were 5.70 (-2%), while average revenue per test was ₹412 (+15%).

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.